Strata Critical Medical, Inc. (SRTA)
Every FINRA and SEC series the site collects for Strata Critical Medical, Inc.: short interest with days to cover, daily short sale volume, fails to deliver and Form 4 insider trades. Listed on Nasdaq, classified by the SEC as services-health services.
4.5M
Short interest
settlement 2026-08-31
5.5
Days to cover
+7.9% vs prior
72.7%
Short share of volume
2026-09-17
1,000
Fails to deliver
settlement 2026-08-24
Mon 9 Nov
Next earnings
estimated; last year 2025-11-10
-$29K
Insider flow, 90 days
0 buys, 1 sells
As of 2026-09-17.
Short interest
FINRA, twice a month; the last 12 months shown, all 25 settlements in the JSONAs of 31 August 2026, short interest in SRTA is 4,525,352 shares, up 323,673 shares over the last month. Over the last 25 readings it ranged from 2,138,637 shares (30 September 2025) to 7,824,961 shares (15 June 2026). At the reported average volume of 820K shares a day that is 5.5 days to cover, elevated.
Embed this chartkeeps the attribution line it carries
<iframe src="https://xoomar.com/embed/stocks/srta" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-08-31 | 4,525,352 | +7.9% | 820,057 | 5.52 |
| 2026-08-14 | 4,194,992 | -0.2% | 1,290,425 | 3.25 |
| 2026-07-31 | 4,201,679 | -2.9% | 971,950 | 4.32 |
| 2026-07-15 | 4,327,351 | +6.2% | 963,671 | 4.49 |
| 2026-06-30 | 4,075,056 | -47.9% | 1,622,698 | 2.51 |
| 2026-06-15 | 7,824,961 | +56.8% | 1,087,102 | 7.20 |
| 2026-05-29 | 4,991,225 | -27.4% | 1,043,171 | 4.78 |
| 2026-05-15 | 6,877,454 | +7.5% | 1,156,568 | 5.95 |
| 2026-04-30 | 6,398,485 | +8.3% | 677,080 | 9.45 |
| 2026-04-15 | 5,907,747 | -20.4% | 637,344 | 9.27 |
| 2026-03-31 | 7,422,968 | +12.9% | 687,997 | 10.79 |
| 2026-03-13 | 6,575,479 | +18.4% | 1,037,850 | 6.34 |
| 2026-02-27 | 5,556,017 | -12.9% | 637,975 | 8.71 |
| 2026-02-13 | 6,381,615 | +6.5% | 743,274 | 8.59 |
| 2026-01-30 | 5,991,211 | -0.7% | 950,701 | 6.30 |
| 2026-01-15 | 6,031,295 | +9.4% | 982,184 | 6.14 |
| 2025-12-31 | 5,511,020 | -8.1% | 754,626 | 7.30 |
| 2025-12-15 | 5,998,697 | +8.7% | 894,976 | 6.70 |
| 2025-11-28 | 5,516,979 | +37.9% | 987,252 | 5.59 |
| 2025-11-14 | 3,999,733 | +53.9% | 998,234 | 4.01 |
| 2025-10-31 | 2,599,765 | +8.9% | 589,725 | 4.41 |
| 2025-10-15 | 2,386,125 | +11.6% | 738,643 | 3.23 |
| 2025-09-30 | 2,138,637 | -28.3% | 1,340,492 | 1.60 |
| 2025-09-15 | 2,983,500 | +22.4% | 626,535 | 4.76 |
Daily short volume
FINRA Reg SHO, last 60 sessions. JSONAs of 17 September 2026, the short share of SRTA volume is 72.7%, down 10.6 points over the last five sessions. Over the last 52 readings it ranged from 18.9% (30 July 2026) to 83.4% (10 September 2026). The latest reading is 22.5 points above the 30-session average of 50.3%, on 170K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-09-17 | 124K | 170K | 72.7% | 0 |
| 2026-09-16 | 92K | 156K | 59.1% | 0 |
| 2026-09-15 | 120K | 197K | 60.7% | 2,271 |
| 2026-09-14 | 140K | 284K | 49.3% | 0 |
| 2026-09-11 | 186K | 329K | 56.6% | 3,649 |
| 2026-09-10 | 265K | 318K | 83.4% | 0 |
| 2026-09-09 | 143K | 317K | 45.1% | 0 |
| 2026-09-08 | 145K | 364K | 39.7% | 0 |
| 2026-09-04 | 93K | 284K | 32.7% | 0 |
| 2026-09-03 | 135K | 315K | 42.8% | 13,577 |
| 2026-09-02 | 194K | 486K | 39.9% | 5,845 |
| 2026-09-01 | 149K | 375K | 39.9% | 0 |
| 2026-08-31 | 114K | 330K | 34.7% | 1,090 |
| 2026-08-28 | 101K | 183K | 55.2% | 0 |
| 2026-08-27 | 87K | 283K | 30.7% | 4,000 |
| 2026-08-26 | 76K | 150K | 50.5% | 0 |
| 2026-08-25 | 172K | 378K | 45.6% | 0 |
| 2026-08-24 | 247K | 350K | 70.6% | 1,411 |
| 2026-08-21 | 168K | 374K | 44.9% | 0 |
| 2026-08-20 | 172K | 456K | 37.7% | 0 |
| 2026-08-19 | 161K | 245K | 65.6% | 0 |
| 2026-08-18 | 190K | 314K | 60.3% | 4 |
| 2026-08-17 | 108K | 189K | 57.3% | 47 |
| 2026-08-14 | 154K | 232K | 66.1% | 0 |
| 2026-08-13 | 128K | 248K | 51.7% | 800 |
| 2026-08-12 | 143K | 276K | 51.7% | 1,900 |
| 2026-08-11 | 161K | 443K | 36.3% | 0 |
| 2026-08-10 | 180K | 494K | 36.3% | 92 |
| 2026-08-07 | 156K | 434K | 36.0% | 0 |
| 2026-08-06 | 208K | 381K | 54.6% | 0 |
Fails to deliver
SEC, by settlement date. JSONAs of 24 August 2026, the fails-to-deliver balance in SRTA is 1,000 shares, down 2,139 shares over the last settlement date. Over the last 52 readings it ranged from 22 shares (13 April 2026) to 240,040 shares (27 April 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-08-24 | 1,000 | $6.24 | $6K |
| 2026-08-20 | 3,139 | $5.89 | $18K |
| 2026-08-03 | 4,353 | $5.02 | $22K |
| 2026-07-23 | 9,359 | $5.08 | $48K |
| 2026-07-17 | 597 | $5.23 | $3K |
| 2026-06-30 | 859 | $5.18 | $4K |
| 2026-06-15 | 807 | $5.43 | $4K |
| 2026-06-12 | 13,880 | $5.49 | $76K |
| 2026-06-11 | 895 | $5.48 | $5K |
| 2026-05-29 | 3,400 | $6.47 | $22K |
| 2026-05-18 | 3,045 | $5.22 | $16K |
| 2026-05-13 | 983 | $5.47 | $5K |
| 2026-05-01 | 2,051 | $5.02 | $10K |
| 2026-04-27 | 240,040 | $4.92 | $1.2M |
| 2026-04-20 | 4,958 | $4.57 | $23K |
| 2026-04-16 | 2,133 | $4.49 | $10K |
| 2026-04-13 | 22 | $4.04 | $89 |
| 2026-04-10 | 559 | $4.05 | $2K |
| 2026-04-07 | 578 | $4.20 | $2K |
| 2026-04-06 | 2,478 | $4.15 | $10K |
| 2026-03-30 | 1,095 | $4.14 | $5K |
| 2026-03-27 | 1,481 | $4.25 | $6K |
| 2026-03-25 | 9,591 | $4.31 | $41K |
| 2026-03-17 | 12,496 | $4.55 | $57K |
| 2026-03-16 | 2,422 | $4.56 | $11K |
| 2026-03-13 | 24,810 | $4.66 | $116K |
| 2026-03-12 | 13,798 | $4.72 | $65K |
| 2026-03-11 | 10,042 | $4.65 | $47K |
| 2026-03-10 | 8,636 | $4.57 | $39K |
| 2026-03-09 | 50,821 | $4.54 | $231K |
Insider trades
SEC Form 4, newest first, 50 of 74 shown. JSONInsiders at SRTA reported 1 open-market sell worth $29K in the last 90 days and no open-market buys. Sells alone are a weak signal; insiders sell for tax, diversification and estate reasons all the time. Latest filing: Love Reginald on 2026-08-10.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-08-10 | Love Reginald | n/a | Sell | 5K | $5.75 | $29K | 146K |
| 2026-07-31 | Wunsch Scott M | CEO, Logistics | Tax withholding | 14K | $5.09 | $71K | 669K |
| 2026-07-31 | Tomkiel Melissa M. | Co-CEO and General Counsel | Tax withholding | 212K | $5.09 | $1.1M | 2.1M |
| 2026-07-31 | Heyburn William A. | Co-CEO and CFO | Tax withholding | 199K | $5.09 | $1.0M | 1.7M |
| 2026-07-31 | Cohen Amir | Chief Accounting Officer | Tax withholding | 34K | $5.09 | $173K | 182K |
| 2026-07-30 | WIESENTHAL ROBERT S | n/a | Grant | 50K | $0.00 | $0 | 5.3M |
| 2026-07-30 | Wunsch Scott M | CEO, Logistics | Grant | 57K | $0.00 | $0 | 683K |
| 2026-07-30 | Tomkiel Melissa M. | Co-CEO and General Counsel | Grant | 207K | $0.00 | $0 | 2.3M |
| 2026-07-30 | Tomkiel Melissa M. | Co-CEO and General Counsel | Grant | 209K | $0.00 | $0 | 2.1M |
| 2026-07-30 | PHILIP EDWARD M | n/a | Grant | 31K | $0.00 | $0 | 265K |
| 2026-07-30 | Love Reginald | n/a | Grant | 38K | $0.00 | $0 | 152K |
| 2026-07-30 | LAUCK ANDREW | n/a | Grant | 35K | $0.00 | $0 | 171K |
| 2026-07-30 | Heyburn William A. | Co-CEO and CFO | Grant | 179K | $0.00 | $0 | 1.9M |
| 2026-07-30 | Heyburn William A. | Co-CEO and CFO | Grant | 181K | $0.00 | $0 | 1.7M |
| 2026-07-30 | Cook William L. III | n/a | Grant | 44K | $0.00 | $0 | 98K |
| 2026-07-30 | Cohen Amir | Chief Accounting Officer | Grant | 27K | $0.00 | $0 | 216K |
| 2026-07-30 | Cohen Amir | Chief Accounting Officer | Grant | 42K | $0.00 | $0 | 188K |
| 2026-06-08 | Wunsch Scott M | CEO, Logistics | Tax withholding | 6K | $5.87 | $33K | 626K |
| 2026-06-08 | Tomkiel Melissa M. | Co-CEO and General Counsel | Tax withholding | 30K | $5.87 | $175K | 1.9M |
| 2026-06-08 | Cohen Amir | Chief Accounting Officer | Tax withholding | 5K | $5.87 | $27K | 147K |
| 2026-06-08 | Heyburn William A. | Co-CEO and CFO | Tax withholding | 32K | $5.87 | $186K | 1.5M |
| 2026-06-08 | Tomkiel Melissa M. | Co-CEO and General Counsel | Sell | 30K | $5.87 | $175K | 1.9M |
| 2026-06-08 | Wunsch Scott M | CEO, Logistics | Sell | 6K | $5.87 | $33K | 626K |
| 2026-06-08 | Heyburn William A. | Co-CEO and CFO | Sell | 32K | $5.87 | $186K | 1.5M |
| 2026-06-08 | Cohen Amir | Chief Accounting Officer | Sell | 5K | $5.87 | $27K | 147K |
| 2026-05-22 | Cohen Amir | Chief Accounting Officer | Sell | 41K | $5.91 | $240K | 151K |
| 2026-05-21 | Cohen Amir | Chief Accounting Officer | Sell | 10K | $5.79 | $60K | 192K |
| 2026-05-11 | Cohen Amir | Chief Accounting Officer | Sell | 14K | $5.79 | $83K | 202K |
| 2026-04-24 | Wunsch Scott M | CEO, Logistics | Tax withholding | 14K | $4.92 | $68K | 631K |
| 2026-04-24 | Tomkiel Melissa M. | Co-CEO and General Counsel | Tax withholding | 322K | $4.92 | $1.6M | 1.9M |
| 2026-04-24 | Heyburn William A. | Co-CEO and CFO | Tax withholding | 302K | $4.92 | $1.5M | 1.6M |
| 2026-04-24 | Cohen Amir | Chief Accounting Officer | Tax withholding | 41K | $4.92 | $202K | 216K |
| 2026-04-23 | Wunsch Scott M | CEO, Logistics | Grant | 57K | $0.00 | $0 | 645K |
| 2026-04-23 | Tomkiel Melissa M. | Co-CEO and General Counsel | Grant | 630K | $0.00 | $0 | 2.2M |
| 2026-04-23 | Heyburn William A. | Co-CEO and CFO | Grant | 546K | $0.00 | $0 | 1.9M |
| 2026-04-23 | Cohen Amir | Chief Accounting Officer | Grant | 84K | $0.00 | $0 | 257K |
| 2026-03-16 | Wunsch Scott M | CEO, Trinity Air Medical | Grant | 18K | $0.00 | $0 | 588K |
| 2026-03-08 | Wunsch Scott M | CEO, Trinity Air Medical | Tax withholding | 4K | $4.54 | $16K | 570K |
| 2026-03-08 | Tomkiel Melissa M. | Co-CEO and General Counsel | Tax withholding | 29K | $4.54 | $133K | 1.6M |
| 2026-03-08 | Heyburn William A. | Co-CEO and CFO | Tax withholding | 31K | $4.54 | $142K | 1.3M |
| 2026-03-08 | Cohen Amir | Chief Accounting Officer | Tax withholding | 2K | $4.54 | $11K | 179K |
| 2026-02-24 | Wunsch Scott M | CEO, Trinity Air Medical | Grant | 51K | $0.00 | $0 | 573K |
| 2026-02-24 | Cohen Amir | Chief Accounting Officer | Grant | 64K | $0.00 | $0 | 182K |
| 2026-01-02 | Tomkiel Melissa M. | Co-CEO and General Counsel | Option exercise | 277K | $0.18 | $50K | 1.6M |
| 2025-12-10 | Tomkiel Melissa M. | Co-CEO and General Counsel | Tax withholding | 34K | $4.38 | $149K | 1.4M |
| 2025-12-10 | Wunsch Scott M | CEO, Trinity Air Medical | Tax withholding | 22K | $4.38 | $95K | 293K |
| 2025-12-10 | Heyburn William A. | Co-CEO and CFO | Tax withholding | 35K | $4.38 | $155K | 1.4M |
| 2025-12-10 | Cohen Amir | Chief Accounting Officer | Tax withholding | 4K | $4.38 | $16K | 118K |
| 2025-12-09 | Heyburn William A. | Co-CEO and CFO | Buy | 17K | $4.47 | $76K | 1.4M |
| 2025-12-05 | LAUCK ANDREW | n/a | Buy | 5K | $4.37 | $22K | 136K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are the rarer, stronger signal.
Planned sales (Form 144)
Newest first. JSON3 Form 144 notices on file for SRTA worth $459K at the prices reported; 0 in the last 90 days worth $0. Latest: AMIR COHEN filed on 2026-05-11 to sell 65,181 shares ($363K) from 2026-05-11.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-05-11 | AMIR COHENOfficer | 65K | $363K | 0.075% | 2026-05-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-20 | Reginald Lamonte LoveDirector | 11K | $48K | 0.013% | 2025-11-20 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-19 | Reginald Lamonte LoveDirector | 11K | $47K | 0.013% | 2025-11-19 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Large holders (13D and 13G)
One row per reporting person, newest filing first. JSON15 holders above 5% have filed on SRTA, 1 on Schedule 13D (active intent). The largest reported stake is Steele ExpCo Holdings, LLC at 9.0% of the class (7,923,000 shares), filed 2026-08-20 for an event on 2026-06-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-20 | 13G/Ano. 3 | Steele ExpCo Holdings, LLCother entity | 7.9M | 9.0% | 2026-06-30 |
| 2026-08-20 | 13G/Ano. 3 | KSL Capital Partners V GP, LLCother entity | 7.9M | 9.0% | 2026-06-30 |
| 2026-08-20 | 13G/Ano. 3 | Eric Charles Resnickindividual | 7.9M | 9.0% | 2026-06-30 |
| 2026-07-08 | 13G/Ano. 7 | Catherine D. Woodparent holding company, individual | 2.7M | 3.2% | 2026-06-30 |
| 2026-07-08 | 13G/Ano. 7 | ARK Investment Management LLCinvestment adviser | 2.7M | 3.2% | 2026-06-30 |
| 2026-06-17 | 13G | Matthew A. Drapkinindividual | 4.4M | 5.1% | 2026-06-11 |
| 2026-06-17 | 13G | Northern Right Capital Management, L.P.partnership, investment adviser | 4.4M | 5.1% | 2026-06-11 |
| 2026-06-17 | 13G | BC Advisors LLCinvestment adviser, other entity | 4.4M | 5.1% | 2026-06-11 |
| 2026-06-17 | 13G | Northern Right Long Only Master Fund LPpartnership | 1.7M | 1.9% | 2026-06-11 |
| 2026-06-17 | 13G | Northern Right Fund GP LLCother entity | 1.7M | 1.9% | 2026-06-11 |
| 2026-06-17 | 13G | Northern Right Capital (QP), L.P.partnership | 1.7M | 1.9% | 2026-06-11 |
| 2026-05-08 | 13D/Ano. 3 | Krstic Veliborindividual, individual | 0 | 0.0% | 2026-05-07 |
| 2026-04-30 | 13G/Ano. 6 | ARK Investment Management LLCinvestment adviser | 7.5M | 8.6% | 2026-03-31 |
| 2026-04-30 | 13G/Ano. 6 | Catherine D. Woodparent holding company, individual | 7.5M | 8.6% | 2026-03-31 |
| 2026-04-16 | 13D/Ano. 2 | Krstic Veliborindividual, individual | 1.5M | 16.2% | 2026-04-15 |
| 2026-04-08 | 13D/Ano. 1 | Krstic Veliborindividual, individual | 1.1M | 12.4% | 2026-04-08 |
| 2026-04-07 | 13D | Krstic Veliborindividual | 764K | 8.3% | 2026-04-01 |
| 2026-01-21 | 13G | BlackRock, Inc.parent holding company | 4.4M | 5.1% | 2025-12-31 |
| 2025-11-14 | 13G/Ano. 1 | Third Point LLCother entity | 5.0M | 5.8% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 1 | Daniel S. Loebindividual | 5.0M | 5.8% | 2025-09-30 |
| 2025-11-04 | 13G/Ano. 5 | ARK Investment Management LLCinvestment adviser | 6.4M | 7.5% | 2025-09-30 |
| 2025-11-04 | 13G/Ano. 5 | Catherine D. Woodparent holding company, individual | 6.4M | 7.5% | 2025-09-30 |
| 2025-10-17 | 13G/Ano. 1 | BlackRock, Inc.parent holding company | 4.2M | 5.0% | 2025-09-30 |
13F holders
Tracked managers holding SRTA at their latest 13F. JSON6 of the 30 tracked managers held SRTA at their latest 13F, $45.1M in total at quarter-end prices. Third Point is the largest at $26.4M (0.6% of its portfolio) as of 2026-06-30. Over the prior quarter 3 added shares and 2 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Third Point | 2026-06-30 | 5.0M | $26.4M | 0.56% | 0 |
| ARK Investment Management | 2026-06-30 | 2.7M | $14.4M | 0.09% | -4.7M |
| Renaissance Technologies | 2026-06-30 | 492K | $2.6M | 0.00% | +18K |
| AQR Capital Management | 2026-06-30 | 140K | $736K | 0.00% | +7K |
| Citadel Advisors | 2026-06-30 | 108K | $568K | 0.00% | -294K |
| Point72 Asset Management | 2026-06-30 | 93K | $492K | 0.00% | +26K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 2026 (quarter ended 2026-06-30) Strata Critical Medical, Inc. reported revenue of $72.5M, up 60.7% from the same quarter a year earlier, and net loss of $10.5M (-0.12 diluted EPS). In FY 2025 it generated -$48.9M of operating cash flow.
- Cash
- $16.3M
- Equity
- $279.3M
- Total assets
- $332.7M
- Shares outstanding
- 88,466,806
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $72.5M | -$10.5M | -14.5% | -0.12 |
| Q1 2026 | 2026-03-31 | $67.4M | $2.2M | 3.2% | 0.03 |
| Q4 2025derived | 2025-12-31 | $66.8M | n/a | n/a | n/a |
| Q3 2025 | 2025-09-30 | $49.3M | $57.4M | 116.5% | 0.70 |
| Q2 2025 | 2025-06-30 | $45.1M | -$3.7M | -8.3% | -0.05 |
| Q1 2025 | 2025-03-31 | $35.9M | -$3.5M | -9.7% | -0.04 |
| Q4 2024derived | 2024-12-31 | -$8.7M | n/a | n/a | n/a |
| Q3 2024 | 2024-09-30 | $36.1M | -$2.0M | -5.4% | -0.03 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $197.1M | n/a | -$48.9M | $9.6M | $0 | n/a |
| FY 2024 | 2024-12-31 | $146.8M | n/a | -$2.5M | $30.9M | $244K | n/a |
| FY 2023 | 2023-12-31 | $225.2M | n/a | -$32.3M | $2.1M | $0 | n/a |
| FY 2022 | 2022-12-31 | $146.1M | -$27.3M | -$37.1M | $730K | n/a | n/a |
| FY 2021 | 2021-09-30 | $50.5M | -$40.1M | -$15.6M | $297K | n/a | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are cash paid to repurchase common stock in the year (XBRL PaymentsForRepurchaseOfCommonStock), not authorizations. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-28 from the cover page.
What this page is
Strata Critical Medical, Inc. in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page pulls every series the site collects for one ticker onto one URL, keyed by the SEC's own ticker list, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a summary sentence built from the rows (last value, change, range with dates) and its own JSON and CSV links. Nothing on the page is written by a model; the sentences change only when the data does. A page exists only for companies with data in at least two series, and every section says when its source last updated.
This page follows Strata Critical Medical, Inc. (SRTA), SEC CIK 1779128, listed on Nasdaq, classified by the SEC as services-health services. The cross-market tables live on the short interest and insider transactions hubs.
Source and method
- Short interest
- FINRA consolidated short interestTwice a month, about eight business days after settlement. Latest 2026-08-31.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesEvery trading day, loaded the following morning. Latest 2026-09-17.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataTwice a month, a few weeks after the half month ends. Latest 2026-08-24.JSON and CSV
- Planned sales
- SEC EDGAR Form 144EDGAR read every 30 minutes; a notice is filed on or before the sell order. Latest 2026-05-11.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GEDGAR read every 30 minutes; 13D within five business days of crossing 5%, 13G on the passive schedule. Latest 2026-08-20.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRQuarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC XBRL company factsRefreshed weekly from the SEC's structured data; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K Item 2.02 (full-text search)EDGAR full-text search read twice a day; the estimate is last year's date plus 52 weeks. Latest 2026-08-04.JSON and CSV
- Insider trades
- SEC EDGAR Form 4EDGAR read every 30 minutes; filings are due two business days after the trade. Latest 2026-08-10.JSON and CSV
- Company record
- EDGAR filing index for CIK 1779128Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 30 requests a minute without a key, 120 a minute with a key from a free account.
Data checks. Every dataset is checked against its source once a day. This dataset passed the last run, 18 Sep 05:40 UTC.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a crowded short are the combination that has historically preceded squeezes; insider sells next to a crowded short are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as services-health services
- WGSGeneDx Holdings Corp.
- LFSTLifeStance Health Group, Inc.
- OMDAOmada Health, Inc.
- TEAMAtlassian Corp
- CVNACARVANA CO.
- CRMSalesforce, Inc.
- METAMeta Platforms, Inc.
- UTHRUNITED THERAPEUTICS Corp
- CRWVCoreWeave, Inc.
- RCGRENN Fund, Inc.
- ANETArista Networks, Inc.
- DDOGDatadog, Inc.
- NETCloudflare, Inc.
- DELLDell Technologies Inc.
- GOOGAlphabet Inc.
- CRWDCrowdStrike Holdings, Inc.
- TPLTexas Pacific Land Corp
- MRNAModerna, Inc.
- COINCoinbase Global, Inc.
- NOWServiceNow, Inc.
- MORNMorningstar, Inc.
- CPIXCUMBERLAND PHARMACEUTICALS INC
- DASHDoorDash, Inc.
- ZMZoom Communications, Inc.
Datasets
Frequently Asked Questions
How much of SRTA is sold short?
What is SRTA's daily short volume?
Does SRTA have fails to deliver?
Are SRTA insiders buying or selling?
Have SRTA insiders filed to sell?
Who owns more than 5% of SRTA?
What did SRTA report last quarter?
Which funds hold SRTA?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.